• Mashup Score: 90

    Working together to help people with COVID-19 feel better faster. Thank you for your interest in ACTIV-6. We are truly grateful to clinical trial participants who help advance science and our understanding of treatments for COVID-19. Learn more from Dr. Susanna Naggie, ACTIV-6 principal investigator, in this video. ACTIV-6 is a unique study that allows participants to take part from anywhere in the U.S. There are no required clinic visits or procedures, and study medications are mailed directly to you.

    Tweet Tweets with this article
    • If you are age 30+ with a recent diagnosis of #COVID19, you may be eligible to join the ACTIV-6 trial from home. It is testing a generic diabetes pill called metformin. Another trial (COVID-Out) showed it ⬇️ risk of #LongCovid by 40%. #MedTwitter Go to https://t.co/ICyJoKAAxn https://t.co/V10d5Zn8rb